Renalytix AI PLC ADR (RNLX): Price and Financial Metrics


Renalytix AI PLC ADR (RNLX): $19.80

1.79 (+9.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RNLX Stock Price Chart Interactive Chart >

Price chart for RNLX

RNLX Price/Volume Stats

Current price $19.80 52-week high $35.71
Prev. close $18.01 52-week low $9.91
Day low $17.99 Volume 166,600
Day high $19.82 Avg. volume 116,874
50-day MA $26.72 Dividend yield N/A
200-day MA $25.84 Market Cap 715.08M

Renalytix AI PLC ADR (RNLX) Company Bio


Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded on March 15,2018 and is headquartered in Penarth, the United Kingdom.


RNLX Latest News Stream


Event/Time News Detail
Loading, please wait...

RNLX Latest Social Stream


Loading social stream, please wait...

View Full RNLX Social Stream

Latest RNLX News From Around the Web

Below are the latest news stories about Renalytix plc that investors may wish to consider to help them evaluate RNLX as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, investor!

William White on InvestorPlace | September 14, 2021

Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model

Targeted testing run rate of 300 diabetic kidney disease patients per week in calendar Q4 2021NEW YORK and SALT LAKE CITY, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney diseas

Yahoo | September 14, 2021

3 High-Growth Healthcare Stocks to Buy in September

All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.

Yahoo | September 9, 2021

Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference

NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (Renalytix or the Company) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference.

Intrado Digital Media | September 3, 2021

Renalytix Appoints Daniel J. Levangie to its Board of Directors

Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic

Intrado Digital Media | August 30, 2021

Read More 'RNLX' Stories Here

RNLX Price Returns

1-mo -22.57%
3-mo -38.13%
6-mo -29.79%
1-year 52.19%
3-year N/A
5-year N/A
YTD 23.75%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7162 seconds.